Ngeunaan Dokter
Dr Naoya Yamazaki mangrupikeun spesialis kanker kulit pangsaéna di Tokyo, Jepang.
Dr Naoya Yamazaki pakait sareng Rumah Sakit Pusat Kanker Nasional, Jepang.
rumah sakit
Pusat Kanker Nasional, Jepang
Spésialisasi
- Onkologi Dermatologi
Prosedur Dilaksanakeun
- Onkologi Dermatologi
- Melanoma
Panilitian & Publikasi
- Adjuvant Nivolumab Versus Ipilimumab di Resected Stage III atanapi IV Melanoma
- Encorafenib Plus Binimetinib Versus Vemurafenib atanapi Encorafenib dina Pasén sareng Melanoma BRAF-mutant (COLUMBUS): A Multicentre, Open-Label, Randomized Phase 3 trial
-
Kasalametan Gemblengna dina Pasén Kalayan Melanoma BRAF-mutant Narima Encorafenib Plus Binimetinib Versus Vemurafenib atanapi Encorafenib (COLUMBUS): A Multicentre, Open-Label, Randomed, Fase 3 Uji coba
-
Sasaran Terapi sareng Imunoterapi pikeun Melanoma di Jepang
-
Gabungan YAP1-MAML2 sareng YAP1-NUTM1 ngulang dina Poroma sareng Porokarsinoma
